Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital.
Institute of Clinical Medicine and Cardiovascular Research Institute, National Yang-Ming University.
Circ J. 2020 Sep 25;84(10):1679-1685. doi: 10.1253/circj.CJ-20-0566. Epub 2020 Sep 9.
The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.
由于 2019 年冠状病毒病（COVID-19）而导致的健康危机震惊了世界，感染和死亡人数已超过 100 万。COVID-19 可从轻症到多器官受累，特别是急性呼吸窘迫综合征。COVID-19 中并不少见的是心脏损伤和心律失常，包括心房颤动（AF）。COVID-19 具有高度传染性，针对该病毒的治疗仍处于早期阶段，并且在很大程度上尚不清楚，这使得在大流行期间管理 AF 患者变得特别具有挑战性。我们描述了 COVID-19 和 AF 之间可能存在的病理生理学联系，以及在此大流行期间对 AF 患者的治疗考虑。
